abstract |
The present invention provides the use of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include the treatment of type 2 diabetes, hypoglycemia, and improving the therapeutic efficacy of metformin. The present invention also provides a pharmaceutical composition comprising a GLP1R agonist and metformin. |